May 14, 2009 / 7:45 AM / 10 years ago

Biofermin Pharm <4517.OS>-2008/09 parent results

   May 14 (Reuters) -
                BIOFERMIN PHAMACEUTICAL CO LTD
                PARENT-ONLY FINANCIAL HIGHLIGHTS
 (in billions of yen unless specified)
               Year ended      Year ended      Year to        Six months to
               Mar 31, 2009    Mar 31, 2008    Mar 31, 2010    Sep 30, 2009
               LATEST          YEAR-AGO        COMPANY         COMPANY   
               RESULTS         RESULTS         FORECASTS       H1 FORECASTS
 Sales               8.54            8.60            8.40            4.27   
                 (-0.7 pct)     (+10.9 pct)         (-1.6%)         (-3.3%)
 Operating           2.09            2.19            1.79            1.08   
                 (-4.5 pct)     (+36.9 pct)        (-14.2%)         (-4.2%)
 Recurring           2.15            1.85            1.87            1.12   
                (+16.3 pct)     (+12.0 pct)        (-13.2%)         (-3.6%)
 Net                 1.38            1.10            1.10             650 mln
                (+25.5 pct)     (+14.1 pct)        (-20.3%)        (-11.2%)
 EPS                  Y117.72          Y93.94          Y93.88          Y55.47
 Shares                12 mln          12 mln                               
 Annual div            Y64.00          Y52.00          Y60.00               
  -Q2 div              Y26.00          Y17.50          Y30.00               
  -Q4 div              Y38.00          Y34.50          Y30.00               
 NOTE - Biofermin Phamaceutical Co Ltd is a specialized manufacturer of Biofermin, medicine for intestinal disorders.
 If there is no Q1 or Q3 dividend, Q2 will in most cases
correspond to the first-half dividend and Q4 to the second-half
dividend announced before a new corporate law in 2006 allowed
companies to pay and report dividends on a quarterly basis.
 For latest earnings estimates made by Toyo Keizai, please
double click on 4517.TK1.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below